Introduction: Who Should Undergo Diagnostics and When

Habitual abortion, also known as recurrent pregnancy loss or recurrent miscarriage, is a condition that deserves careful medical evaluation. This term describes the situation when a woman experiences the spontaneous loss of two or more pregnancies before the baby can survive outside the womb, typically before 20 weeks of pregnancy^[1][4]. Some medical organizations define it as the loss of three or more pregnancies, but many doctors now recommend starting an evaluation after just two consecutive losses^[10].

The decision to undergo diagnostic testing is an important one that couples should make together with their healthcare provider. Not everyone who has had two miscarriages needs extensive testing right away, but an evaluation becomes particularly advisable when specific circumstances are present. Women who are over the age of 35 face a higher risk of recurrent miscarriage and may benefit from earlier evaluation, as age affects both egg quality and the likelihood of chromosomal problems^[10]. Similarly, if you have had previous pregnancy losses or have a family history of genetic problems or birth defects, seeking diagnostic services sooner rather than later can be beneficial.

Understanding when to seek diagnostics also depends on your emotional state and desire for answers. The experience of losing multiple pregnancies causes profound anxiety and frustration^[2]. Some couples feel an urgent need to understand why the losses occurred before attempting another pregnancy, while others may prefer to try again naturally. Both approaches are valid, though having diagnostic information can help identify treatable causes and potentially improve outcomes in future pregnancies.

The timing of seeking help also relates to the emotional toll that repeated losses take. Each miscarriage can trigger grief, sadness, worry, and sometimes guilt, with women often wondering if something they did caused the loss^[14]. Diagnostic evaluation can provide clarity and peace of mind, helping to relieve some of these concerns. Having concrete medical information can also help couples feel more in control of their situation and better equipped to make informed decisions about their reproductive future.

Diagnostic Methods for Identifying Habitual Abortion

Once you and your doctor decide to pursue diagnostic testing, you will go through a comprehensive evaluation designed to identify potential causes of your pregnancy losses. The diagnostic process for habitual abortion is thorough because the causes are varied and sometimes multiple factors contribute to the problem^[4]. Understanding what tests are available and what they reveal helps reduce anxiety about the unknown and prepares you for the evaluation ahead.

Medical History and Physical Examination

The diagnostic journey typically begins with a detailed conversation between you and your healthcare provider. Your doctor will ask about your previous pregnancies, including how far along you were when each loss occurred, whether you experienced any symptoms beforehand, and details about any tissue that was examined after the miscarriage. This information helps doctors understand patterns that might point toward specific causes.

Your doctor will also want to know about your general health, including any chronic conditions you might have such as diabetes, thyroid problems, high blood pressure, or kidney disease. These conditions, when poorly controlled, can contribute to pregnancy loss^[6]. Your family history is equally important, as genetic conditions and a family pattern of miscarriages can suggest inherited factors. Lifestyle factors including smoking, alcohol use, caffeine consumption, and body weight will also be discussed, since these can affect pregnancy outcomes^[8].

A thorough physical examination follows the history-taking. This examination allows your doctor to check for physical abnormalities that might contribute to pregnancy loss, including problems with the structure of your reproductive organs.

Genetic and Chromosomal Testing

Genetic abnormalities are the most common cause of recurrent miscarriage, accounting for about 60 percent of all cases^[10]. Karyotyping is a test that examines the chromosomes of both parents to identify any abnormalities in their genetic makeup. In particular, doctors look for something called balanced translocations, where pieces of chromosomes have rearranged themselves. Parents with balanced translocations are usually healthy themselves, but when they pass genetic material to their baby, it can result in too much or too little genetic information, causing miscarriage^[10].

If tissue from a previous miscarriage was preserved, genetic testing of that tissue can provide valuable information about what went wrong with that specific pregnancy. This testing helps distinguish between random chromosomal errors (which are common and don’t necessarily mean future pregnancies will also be affected) and patterns that suggest an inherited problem^[2].

Blood Tests for Immune and Clotting Disorders

Blood tests form a crucial part of the diagnostic evaluation for habitual abortion. Several types of blood tests are routinely performed to look for different potential causes of pregnancy loss.

Testing for acquired thrombotic disorders is important, particularly screening for antiphospholipid syndrome. This condition causes the blood to clot too easily, which can lead to problems with blood flow to the placenta and result in pregnancy loss. Doctors test for specific antibodies including anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies, and lupus anticoagulant^[6]. Women who test positive for these antibodies and have had three or more pregnancy losses after 10 weeks of gestation are diagnosed with antiphospholipid syndrome.

Thyroid function testing is standard in the evaluation of recurrent pregnancy loss. Both an underactive thyroid (hypothyroidism) and an overactive thyroid (hyperthyroidism) can contribute to miscarriage^[6]. Doctors measure thyroid-stimulating hormone levels to assess how well the thyroid gland is functioning.

Testing for diabetes is also part of the standard workup, since poorly controlled blood sugar can affect pregnancy outcomes^[6]. Screening for hereditary clotting disorders is not routinely recommended for all women with recurrent miscarriage, but may be performed in specific situations under the guidance of a specialist in high-risk pregnancies^[6].

Imaging Studies to Evaluate Uterine Structure

Abnormalities in the structure of the uterus or cervix can contribute to recurrent pregnancy loss. To evaluate the shape and structure of the uterus, doctors use various imaging techniques.

Hysterosalpingography is an X-ray procedure where dye is injected through the cervix into the uterus and fallopian tubes. The dye shows up on X-rays, creating an outline of the inside of the uterus and revealing structural problems such as a uterine septum (a wall of tissue dividing the uterus), fibroids, polyps, or adhesions (scar tissue)^[6].

Saline infusion sonohysterography is an ultrasound technique where sterile salt water is placed inside the uterus through a thin tube. The fluid expands the uterine cavity, making it easier to see the uterine lining and identify abnormalities such as polyps or fibroids that project into the cavity^[6].

Regular ultrasound examinations can also be helpful, particularly transvaginal ultrasound which provides detailed views of the uterus, ovaries, and surrounding structures. These imaging studies help doctors identify treatable structural problems that might be contributing to pregnancy loss.

Hormonal Evaluation

Hormonal imbalances can play a role in recurrent miscarriage, though this is a somewhat controversial area in the medical literature. Some doctors measure progesterone levels in the blood during the second half of the menstrual cycle. Progesterone is a hormone essential for maintaining early pregnancy, and low levels might indicate problems with the corpus luteum, the structure that produces progesterone after ovulation^[2].

Evaluation of the timing and quality of ovulation may also be part of the diagnostic workup. If ovulation is delayed or the egg is “overripe” when fertilization occurs, this may contribute to chromosomal abnormalities in the embryo and subsequent miscarriage^[2].

Testing for Infections

While infections are not a common cause of recurrent pregnancy loss, testing for certain infectious agents may be performed in specific circumstances. Historically, infections such as T-mycoplasmas and Listeria monocytogenes were investigated as potential causes of habitual abortion^[2]. However, routine testing for infectious causes is not standard practice in most modern evaluation protocols unless there is a specific reason to suspect an infection.

Diagnostics for Clinical Trial Qualification

When women with habitual abortion are being considered for participation in clinical trials, additional or more specific diagnostic tests may be required. Clinical trials testing new treatments for recurrent pregnancy loss need to ensure that participants meet specific criteria so that researchers can accurately evaluate whether the treatment being studied is effective.

For enrollment in clinical trials, detailed documentation of previous pregnancy losses is essential. This typically includes medical records confirming the number of miscarriages, the gestational age at which each occurred, and any pathology reports from tissue examination. Many clinical trial protocols specify that participants must have had a certain minimum number of consecutive losses, such as three or more documented spontaneous abortions before 20 weeks of pregnancy^[1].

Chromosomal testing of both parents through karyotyping is often required for clinical trial enrollment. This helps researchers exclude couples with identifiable genetic causes that might confound the study results or who might benefit from different interventions. The goal is often to study populations with unexplained recurrent pregnancy loss, where the cause remains unknown despite thorough evaluation.

Testing for specific antibodies associated with antiphospholipid syndrome is commonly required for trials studying treatments for immune-related causes of recurrent pregnancy loss. The specific tests and the thresholds for positive results are usually clearly defined in the trial protocol. Some studies may require that testing be repeated to confirm persistent antibody levels, as transient antibodies may not indicate true antiphospholipid syndrome.

Uterine imaging studies are frequently part of clinical trial qualification criteria. Trials may require documentation that the uterine cavity is normal or, conversely, may specifically recruit women with certain anatomical abnormalities if the trial is studying surgical correction of these problems. Hysterosalpingography, sonohysterography, or hysteroscopy (a procedure where a thin telescope is inserted through the cervix to directly visualize the inside of the uterus) may be required^[9].

Hormonal testing for clinical trial qualification often includes detailed evaluation of thyroid function, diabetes screening, and sometimes assessment of progesterone levels or other hormones involved in maintaining early pregnancy. If the clinical trial is testing a hormonal treatment, baseline hormone measurements are essential for monitoring changes during the study.

Some clinical trials may also require assessment of the male partner. This might include semen analysis to evaluate sperm quality, since abnormalities in semen parameters have been associated with higher miscarriage risk^[6]. Chromosomal testing of the male partner is typically required if the female partner is being tested.

Before pregnancy is attempted in a clinical trial, baseline blood work establishing normal kidney function, liver function, and blood counts is often performed. This provides a reference point for monitoring potential side effects of treatments being studied. Some trials may also require proof that participants are free of certain infectious diseases.

Clinical trials may specify that diagnostic testing must be performed within a certain timeframe before enrollment, such as within the past six months or one year. This ensures that the information reflects the current medical status of the participant. If previous testing is older than the required timeframe, tests may need to be repeated even if they were normal before.